SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi ($SNY) is trending amidst discussions of potential acquisitions and partnerships, particularly fueled by speculation from the Altimmune ($ALT) community regarding a possible buyout.  The community is weighing the potential benefits of partnerships with companies like $VKTX and $GUTS, while keeping a close eye on developments in the broader pharmaceutical sector and competitive dynamics with companies like $LLY and $NVO.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

XLM is trending amidst market volatility, with community members actively discussing potential accumulation opportunities and key support levels. Some traders are speculating on short-term price movements, while others maintain a long-term bullish outlook, emphasizing utility and future potential. Recent news around treasury initiatives and partnerships may also be contributing to the increased attention.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is trending downwards as concerns emerge regarding decelerating growth in core markets and some analysts pointing to an unstable "boom-bust viral hit model". Despite strong user engagement and platform growth, the stock faces scrutiny over profitability and rising expenses, leading to a mixed sentiment among investors. Additionally, concerns about child safety and potential legal hurdles contribute to the negative pressure.

Sound Group, Inc. is global audio-centric social and entertainment company, which engages in the provision of an audio platform. It focuses on audio entertainment and social networking. The company was founded by Jinnan Lai and Ning Ding in November 2010 and is headquartered in Singapore.

Sound Group Inc - ADR

Sound Group Inc

Sound Group Inc ($SOGP) is trending amid discussions around option trading and potential for high ROI, with some traders pointing to actionable alerts for both calls and puts. While some community members express bullish sentiment with mentions of gearing up, buy zones, and positive earnings growth, others warn of potential pump-and-dump schemes due to its history and association with Asian-based companies. The stock's volatility and past performance are also being heavily debated.

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Bath & Body Works Inc

BBWI is trending due to a mix of factors, including recent analyst upgrades, strong Q3 earnings, and raised full-year guidance. The community is discussing whether the recent surge is justified and if the stock is undervalued given its low P/E ratio and growth potential. Bullish sentiment is building around holiday sales expectations and the company's strategic initiatives, though some remain cautious.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals ($IONS) is trending as discussions revolve around potential catalysts and upcoming FDA decisions, particularly for Olezarsen and Donidalorsen. Community sentiment seems positive, with some highlighting the company's innovative RNA-targeted approach and commercial growth potential; however, insider selling and competitor advancements are also being closely watched.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending amid discussions about its price potential, with some community members anticipating a rise while others express skepticism and frustration over its performance compared to Bitcoin and other altcoins like Cardano. The community is also buzzing about the Algorand Foundation's new 13-week onchain adventure called Algoland which offers quests and prizes. Concerns around a possible change to the tokenomics and supply are being discussed as well.

BlackPearl.Chain is pushing decentralization into the future with a third-generation public blockchain. It’s network achieves blazing transaction speeds (Millions TPS) using Sharding and a VRF lightning-fast consensus mechanism built in-house. Finality is achieved in under three seconds with revolutionary P2P, Its speed and security make it the perfect platform for applications like digital asset trading, social media messaging, payment processing, supply chain tracking, and other high-scale use cases.

BlackPearl

BlackPearl (BPLC) is trending as community members express strong conviction in its long-term potential and future listings on major exchanges. Optimism is fueled by the project's team and perceived potential within the banking and monetary system, with some anticipating significant market cap growth. The conversation highlights both excitement for immediate gains and a belief in the project's long-term investment viability.

Vanguard Malvern Funds - Vanguard Short-Term Inflation-Protected Securities Index Fund

Vanguard Short-Term Inflation-Protected Securities ETF

VTIP is trending as investors evaluate its role as an inflation hedge amid ongoing economic uncertainty and debate the Fed's monetary policy. Community discussions revolve around recession indicators and whether current market reactions are overblown, with some seeing VTIP as a safe haven for stable income. Additionally, large institutional inflows into VTIP by dark pools have been noted.

Gitlab, Inc. provides code hosting and collaboration platform services. It offers continuous integration, source code management, out-of-the-box pipelines, agile development, and value stream management. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in Dover, DE.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab ($GTLB) is trending amid both positive and negative sentiment; some traders are highlighting a recent Morgan Stanley price target increase while others point to a Mizuho downgrade. The community is also actively discussing potential acquisition rumors, particularly involving Datadog ($DDOG), with some speculating on a possible bidding war. Despite mixed opinions, there's ongoing discussion about GitLab's positioning in the DevSecOps space and its potential for growth in the AI landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SG Americas Securities LLC Raises Stake in BioCryst Pharmaceuticals, Inc. $BCRX

SG Americas Securities LLC lifted its stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) by 441.5% during the 2nd quarter, according to the company in its most recent...

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the fourteen analysts that are presently covering the firm, MarketBeat...

M&G PLC Makes New Investment in BioCryst Pharmaceuticals, Inc. $BCRX

M&G PLC acquired a new stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and...

Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for the...

BioCryst Pharmaceuticals, Inc. $BCRX Stake Lifted by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. increased its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) by 20.7% during the 2nd quarter, according to the company...

HC Wainwright Has Positive Estimate for BCRX FY2025 Earnings

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) - Stock analysts at HC Wainwright increased their FY2025 earnings estimates for BioCryst Pharmaceuticals in a research note issued to...

Citizens Jmp Has Lowered Expectations for BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price

Citizens Jmp reduced their price objective on BioCryst Pharmaceuticals from $27.00 to $25.00 and set a "market outperform" rating for the company in a research note on Wednesday...

Ardelyx (ARDX) Reports Break-Even Earnings for Q3

Ardelyx (ARDX) delivered earnings and revenue surprises of +100.00% and +10.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Madrigal (MDGL) Expected to Beat Earnings Estimates: Should You Buy?

Madrigal (MDGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy?

BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Current Price	$6.93
Prev Close	$7.03
Open	$7.03
Dividend Yield	0.00%
50-Day Moving Average	$7.22
Beta	1.01
Avg. Volume	6.82M
PE Ratio	-147.36

52-Week High	$11.31
52-Week Low	$6.00
Market Capitalization	$1.47B
EPS (Annual)	-$0.43
Price to Book	-3.78
Revenue Per Employee	$777,089.66
Enterprise Value/EBITDA	N/A

BCRX
Biocryst Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BCRX News

BCRXBiocryst Pharmaceuticals Inc.